These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 20590576)
1. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. Ho WS; Patel S; Thompson JR; Roberts CJ; Stuhr KL; Hillard CJ Br J Pharmacol; 2010 Jun; 160(3):736-46. PubMed ID: 20590576 [TBL] [Abstract][Full Text] [Related]
2. The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat. Patel S; Gerrits R; Muthian S; Greene AS; Hillard CJ Neurosci Lett; 2002 Dec; 335(2):95-8. PubMed ID: 12459507 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Hampson RE; Miller F; Palchik G; Deadwyler SA Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475 [TBL] [Abstract][Full Text] [Related]
4. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system. Pfitzer T; Niederhoffer N; Szabo B Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243 [TBL] [Abstract][Full Text] [Related]
5. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990 [TBL] [Abstract][Full Text] [Related]
6. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329 [TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region. Sheinin A; Talani G; Davis MI; Lovinger DM J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350 [TBL] [Abstract][Full Text] [Related]
8. Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices. Mendiguren A; Pineda J Br J Pharmacol; 2009 Nov; 158(6):1579-87. PubMed ID: 19845674 [TBL] [Abstract][Full Text] [Related]
10. O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. Jergas B; Schulte K; Bindila L; Lutz B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):621-8. PubMed ID: 24853577 [TBL] [Abstract][Full Text] [Related]
11. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala. Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017 [TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory. Atsak P; Hauer D; Campolongo P; Schelling G; McGaugh JL; Roozendaal B Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3504-9. PubMed ID: 22331883 [TBL] [Abstract][Full Text] [Related]
13. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex. Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. Hillard CJ; Ho WS; Thompson J; Gauthier KM; Wheelock CE; Huang H; Hammock BD Br J Pharmacol; 2007 Nov; 152(5):691-8. PubMed ID: 17891162 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors. Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Tóth ZE; Balla A; Catt KJ; Hunyady L J Biol Chem; 2012 Sep; 287(37):31540-50. PubMed ID: 22787147 [TBL] [Abstract][Full Text] [Related]
16. Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2. Jelsing J; Galzin AM; Guillot E; Pruniaux MP; Larsen PJ; Vrang N Brain Res Bull; 2009 Mar; 78(4-5):202-10. PubMed ID: 19038314 [TBL] [Abstract][Full Text] [Related]
17. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation. Makwana R; Molleman A; Parsons ME Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566 [TBL] [Abstract][Full Text] [Related]
18. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Melis M; Pillolla G; Bisogno T; Minassi A; Petrosino S; Perra S; Muntoni AL; Lutz B; Gessa GL; Marsicano G; Di Marzo V; Pistis M Neurobiol Dis; 2006 Oct; 24(1):15-27. PubMed ID: 16762556 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells. Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126 [TBL] [Abstract][Full Text] [Related]
20. CB(1) cannabinoid receptor activation dose dependently modulates neuronal activity within caudal but not rostral song control regions of adult zebra finch telencephalon. Soderstrom K; Tian Q Psychopharmacology (Berl); 2008 Aug; 199(2):265-73. PubMed ID: 18509622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]